The UCI ADRC Neuropathology (NP) Core links clinical evaluations with definitive neuropathological diagnoses. Neuropathology remains the definitive method for diagnosing Alzheimer's disease (AD). The UCI ADRC cohorts consist of a longitudinal cohort, and two unique patient populations: adults with Down syndrome and individuals over 90 years of age ( 90+ ), representing cohorts at high risk of developing dementia. Down syndrome represents the single most prevalent cause of early-onset AD, whereas the 90+ cohort represents subjects with a high rate of conversion to dementia. Both cohorts provide unique opportunities to study the transition of `cognitively normal' to dementia. The overarching goal of the NP Core is to provide the infrastructure to support research on all three ADRC cohorts that aim to elucidate the underlying mechanisms that define normal aging, the transition to MCI, and the subsequent transition from MCI to AD/dementia. As part of its mission, the UCI NP Core disseminates well-characterized tissues, biospecimens and reagents to basic scientists at UCI and abroad to stimulate and facilitate research in AD and other age-associated neurodegenerative diseases. Using standardized methods for processing, the NP Core supports multi-center collaborative studies. Additionally, the NP Core seeks to innovate by establishing infrastructure to support novel technologies, techniques, and data collection to increase the value of the stored tissue and biospecimens. Lastly, the NP Core reports important AD research findings in collaboration with the Education Core. In order to achieve the goals of the NP Core, we propose seven specific aims: (1) Perform an accurate and timely autopsy of the ADRC cohorts (Longitudinal, Down syndrome, and 90+) and provide a standardized neuropathological report to the Data Management and Statistics Core for deposition with NACC, and to the Clinical Core for dissemination to the families of the deceased participants and their physicians; (2) Store, catalog, and disseminate brain tissue and biospecimens from ADRC subjects; (3) Store, catalog, and disseminate novel reagents made by UCI investigators; (4) Support and consult on ADRC projects, ADRC pilot studies, and studies on AD mechanisms by investigators funded by other means, including ADC collaborative projects; (5) Develop and establish new core functions to facilitate innovative research to study the transition of MCI to AD; (6) Participate in the public education of Chinese-Americans and others; (7) Train pathologists, neurologists, neurosurgeons, neuroscientists, neuropsychologists, and students on the neuropathological features of AD and other dementing disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG016573-20
Application #
9686519
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2019-04-01
Budget End
2020-03-31
Support Year
20
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of California Irvine
Department
Type
DUNS #
046705849
City
Irvine
State
CA
Country
United States
Zip Code
92617
Davis, Jeremy J (2018) Performance validity in older adults: Observed versus predicted false positive rates in relation to number of tests administered. J Clin Exp Neuropsychol 40:1013-1021
Burke, Shanna L; Cadet, Tamara; Maddux, Marlaina (2018) Chronic Health Illnesses as Predictors of Mild Cognitive Impairment Among African American Older Adults. J Natl Med Assoc 110:314-325
Lin, Ming; Gong, Pinghua; Yang, Tao et al. (2018) Big Data Analytical Approaches to the NACC Dataset: Aiding Preclinical Trial Enrichment. Alzheimer Dis Assoc Disord 32:18-27
Agrawal, Sudhanshu; Abud, Edsel M; Snigdha, Shikha et al. (2018) IgM response against amyloid-beta in aging: a potential peripheral protective mechanism. Alzheimers Res Ther 10:81
Kirson, Noam Y; Scott Andrews, J; Desai, Urvi et al. (2018) Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease. J Alzheimers Dis 61:295-307
Kamara, Dennis M; Gangishetti, Umesh; Gearing, Marla et al. (2018) Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease. J Alzheimers Dis 62:1815-1826
Stark, Shauna M; Reagh, Zachariah M; Yassa, Michael A et al. (2018) What's in a context? Cautions, limitations, and potential paths forward. Neurosci Lett 680:77-87
Leal, Stephanie L; Yassa, Michael A (2018) Integrating new findings and examining clinical applications of pattern separation. Nat Neurosci 21:163-173
Weintraub, Sandra; Besser, Lilah; Dodge, Hiroko H et al. (2018) Version 3 of the Alzheimer Disease Centers' Neuropsychological Test Battery in the Uniform Data Set (UDS). Alzheimer Dis Assoc Disord 32:10-17
Kaur, Antarpreet; Edland, Steven D; Peavy, Guerry M (2018) The MoCA-Memory Index Score: An Efficient Alternative to Paragraph Recall for the Detection of Amnestic Mild Cognitive Impairment. Alzheimer Dis Assoc Disord 32:120-124

Showing the most recent 10 out of 518 publications